Performance analysis of BIS (ProShares UltraShort Nasdaq Biotechnology -2x Shares)
Annual Return
Over the past 3 years, BIS has had an average annual return of -27.55%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, BIS has had an average annual return of -15.89%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, BIS has had an average annual return of -24.98%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Apr 8, 2010, BIS has had an average annual return of -32.64%, underperforming the benchmark SPY, which returned +13.96% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -27.27% | -45.00% | +2.56% | -4.88% | -2.38% | -14.29% | -56.25% | -41.36% | +5.52% | -36.93% | +21.61% | -37.57% |
| 2014 | 2013 | 2012 | 2011 | 2010 | |||||||
| -55.42% | -68.88% | -49.13% | -35.82% | -16.53% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.55% | -9.52% | +5.26% | -0% | -5.00% | -15.79% | +0% | -27.27% | |||||
| 2025 | -7.50% | +0% | +13.51% | -4.76% | +7.50% | -6.98% | -10.00% | -11.11% | -6.25% | -16.67% | -16.00% | +4.76% | -45.00% |
| 2024 | -2.56% | +0% | +0% | +13.16% | -9.30% | -7.69% | -11.11% | -3.12% | +6.45% | +6.06% | +0% | +14.29% | +2.56% |
| 2023 | -7.32% | +15.79% | -2.27% | -4.65% | +7.32% | +0% | -2.27% | +0% | +9.30% | +14.89% | -9.26% | -20.41% | -4.88% |
| 2022 | +26.19% | +7.55% | -10.53% | +19.61% | -1.64% | -5.00% | -8.77% | +0% | +1.92% | -16.98% | -11.36% | +5.13% | -2.38% |
| 2021 | -12.24% | +4.65% | +4.44% | -6.38% | +2.27% | -13.33% | -2.56% | -7.89% | +8.57% | +2.63% | +7.69% | -0% | -14.29% |
| 2020 | +12.50% | -2.38% | -4.07% | -27.12% | -17.44% | -4.23% | +1.47% | -2.90% | -2.99% | +6.15% | -20.29% | -10.91% | -56.25% |
| 2019 | -23.56% | -6.16% | +0.73% | +10.14% | +11.84% | -16.47% | +5.63% | +4.67% | +6.37% | -13.77% | -20.14% | -2.61% | -41.36% |
| 2018 | -13.26% | +9.55% | +1.16% | +4.60% | -9.34% | -3.03% | -11.88% | -9.22% | +0.78% | +32.56% | -9.94% | +24.03% | +5.52% |
| 2017 | -10.10% | -12.79% | +1.33% | -3.07% | +7.69% | -16.39% | -6.03% | -9.09% | -0.59% | +12.43% | -1.58% | -3.21% | -36.93% |
Drawdown analysis of BIS (ProShares UltraShort Nasdaq Biotechnology -2x Shares)
The maximum drawdown for the BIS was -99.89%, occurring on Jul 2, 2026. This drawdown has not yet recovered.
The current BIS drawdown is -99.88%.
Since Apr 8, 2010 BIS has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.89% | Jul 6, 2010 | 4022 | Jul 2, 2026 | Ongoing | Ongoing | Ongoing |
| -13.04% | Jun 9, 2010 | 4 | Jun 15, 2010 | 12 | Jul 1, 2010 | 16 |
| -11.83% | May 6, 2010 | 4 | May 12, 2010 | 6 | May 20, 2010 | 10 |
| -9.45% | May 26, 2010 | 5 | Jun 3, 2010 | 3 | Jun 8, 2010 | 8 |
| -6.58% | Apr 27, 2010 | 2 | Apr 29, 2010 | 4 | May 5, 2010 | 6 |
| -2.89% | Apr 8, 2010 | 5 | Apr 15, 2010 | 4 | Apr 21, 2010 | 9 |
| -1.87% | Apr 22, 2010 | 1 | Apr 23, 2010 | 2 | Apr 27, 2010 | 3 |
| -1.43% | Jul 1, 2010 | 1 | Jul 2, 2010 | 1 | Jul 6, 2010 | 2 |